These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Concomitant therapy achieved the best eradication rate for Helicobacter pylori among various treatment strategies. Lee HJ; Kim JI; Lee JS; Jun EJ; Oh JH; Cheung DY; Chung WC; Kim BW; Kim SS World J Gastroenterol; 2015 Jan; 21(1):351-9. PubMed ID: 25574111 [TBL] [Abstract][Full Text] [Related]
7. First-line treatment of Helicobacter pylori in Lebanon: Comparison of bismuth-containing quadruple therapy versus 14-days sequential therapy. Tarhini M; Fayyad-Kazan M; Fayyad-Kazan H; Mokbel M; Nasreddine M; Badran B; Kchour G Microb Pathog; 2018 Apr; 117():23-26. PubMed ID: 29428426 [TBL] [Abstract][Full Text] [Related]
8. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease. Park KN; Hahm JS; Kim HJ Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924 [TBL] [Abstract][Full Text] [Related]
9. Helicobacter pylori and gastric or duodenal ulcer. Prescrire Int; 2016 Jan; 25(167):18-23. PubMed ID: 26942258 [TBL] [Abstract][Full Text] [Related]
10. Gastric MALT lymphoma and Helicobacter pylori. Salar A Med Clin (Barc); 2019 Jan; 152(2):65-71. PubMed ID: 30424932 [TBL] [Abstract][Full Text] [Related]
12. Strategy for the treatment of Helicobacter pylori infection. Shiota S; Yamaoka Y Curr Pharm Des; 2014; 20(28):4489-500. PubMed ID: 24180402 [TBL] [Abstract][Full Text] [Related]
13. Novel and Effective Therapeutic Regimens for Hu Y; Zhu Y; Lu NH Front Cell Infect Microbiol; 2017; 7():168. PubMed ID: 28529929 [No Abstract] [Full Text] [Related]
14. [10-day triple therapy with esomeprazole 40 mg/12 h vs. quadruple concomitant non-bismuth therapy as first line treatment for Helicobacter pylori infection]. Campillo A; Amorena E; Ostiz M; Kutz M; LaIglesia M Gastroenterol Hepatol; 2016 Nov; 39(9):584-589. PubMed ID: 27084668 [TBL] [Abstract][Full Text] [Related]
15. Second-line rescue triple therapy with levofloxacin after failure of non-bismuth quadruple "sequential" or "concomitant" treatment to eradicate H. pylori infection. Gisbert JP; Molina-Infante J; Marin AC; Vinagre G; Barrio J; McNicholl AG Scand J Gastroenterol; 2013 Jun; 48(6):652-6. PubMed ID: 23556551 [TBL] [Abstract][Full Text] [Related]
17. 'Rescue' therapies for the management of Helicobacter pylori infection. Di Mario F; Cavallaro LG; Scarpignato C Dig Dis; 2006; 24(1-2):113-30. PubMed ID: 16699270 [TBL] [Abstract][Full Text] [Related]
18. Management of Helicobacter pylori infection. Costa F; D'Elios MM Expert Rev Anti Infect Ther; 2010 Aug; 8(8):887-92. PubMed ID: 20695744 [TBL] [Abstract][Full Text] [Related]
19. The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults. Fallone CA; Chiba N; van Zanten SV; Fischbach L; Gisbert JP; Hunt RH; Jones NL; Render C; Leontiadis GI; Moayyedi P; Marshall JK Gastroenterology; 2016 Jul; 151(1):51-69.e14. PubMed ID: 27102658 [TBL] [Abstract][Full Text] [Related]
20. Empiric quadruple vs. triple therapy for primary treatment of Helicobacter pylori infection: Systematic review and meta-analysis of efficacy and tolerability. Luther J; Higgins PD; Schoenfeld PS; Moayyedi P; Vakil N; Chey WD Am J Gastroenterol; 2010 Jan; 105(1):65-73. PubMed ID: 19755966 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]